Mode
Text Size
Log in / Sign up
N/A N=52 Randomized Treatment

Online MBCT Program for University Students

Depression in Adolescence

Enrolled (actual)
52
Serious AEs
0.0%
Results posted
Dec 2025
Primary outcome: Primary: BDI-II -Pretest — 12.54; 14.42 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
mindfulness-based cognitive therapy (Behavioral); Mental health education (Other)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Chung Shan Medical University
Primary completion
Jul 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
BDI-II -Pretest
12.54; 14.42
PRIMARY
BDI-II -Posttest
7; 9.87
PRIMARY
WHOQOL-BREF-TW -Pretest
3.38; 3.15; 2.88; 2.65; 26.31; 23.85
PRIMARY
WHOQOL-BREF-TW -Posttest
3.87; 3.48; 3.04; 3.13; 28.13; 25.74
SECONDARY
BAI -Pretest
9.31; 8.65
SECONDARY
BAI -Posttest
5.52; 6.52
SECONDARY
OSA -Pretest
33.62; 30.73; 14.42; 12.96; 13.88; 12.69
SECONDARY
OSA -Posttest
35.3; 32.65; 16.35; 13.83; 15.96; 14.04
SECONDARY
COPM -Pretest
5.93; 4.62; 5.39; 4.22
SECONDARY
COPM -Posttest
7.03; 6.01; 6.85; 6.06

Summary

The goal of this interventional study is to examine the efficacy of the online mindfulness-based cognitive therapy program(MBCT) in youth (18-25 years old) with depressive symptoms. The main questions it aims to answer are: * Whether the program could reduce depressive symptoms in university students. * Whether the program could increase quality of life in university students. * The effectiveness, acceptance, and practicability of the program for university students. Participants in the experimental group would be arranged to attend online mindfulness-based cognitive programs for eight weeks. The control group would be educated the knowledge of mental health to manage their negative emotions.

Eligibility Criteria

Inclusion Criteria

  • Age of 18 and 25
  • Has Beck Depression Inventory-2 (BDI-II) score of at least mild severity, with no upper limit
  • Able to communicate through LINE app
  • Able to read Chinese and willing to participate in research

Exclusion Criteria

  • Meets the Diagnostic and Statistical Manual of Mental Disorders-V, such as schizophrenia, substance abuse, and Bipolar disorder
  • Has ever been diagnosed as any significant physical illness, such as cancer, organ damage, and stroke
  • Refuse to be assigned to different groups randomly
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05804877). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search